课题基金 / 基金详情

DETERMINANTS OF VIRAL MEMBRANE FUSION

DETERMINANTS OF VIRAL MEMBRANE FUSION
病毒膜融合的决定因素
批准号:
2700319
负责人:
Qizhi C. Yao
金额:
$28.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2002-04-30

项目摘要

项目成果

Qizhi C. Yao的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this project is to investigate two novel findings concerning membrane fusion induced by retroviruses and paramyxoviruses. One specific aim will investigate the mechanism by which sequences in the cytoplasmic tail of viral glycoproteins can be a major determinant of membrane fusion activity. The C-terminal segment of the murine leukemia virus Env protein (the R peptide) is a potent inhibitor of virus-induced membrane fusion. Dr Compans will determine the precise amino acid sequences in the R peptide which are required for its fusion-inhibitory activity, and test the hypothesis that the inhibitory activity of the R peptide in a soluble or membrane-anchored form have an effect as a dominant negative inhibitor of fusion activity R peptide may cause a change in the conformation of the external domain of the envelope protein. Dr. Compans previously obtained evidence that a type-specific interaction occurs between the F and HN proteins which is essential for the fusion activity however, no information has been obtained about the precise nature of this interaction. Dr. Compans will determine whether F and HN are physically associated ont he surfaces of virions and/or infected cells, whether the F protein undergoes a conformational change which activates fusion activity, and whether this change requires its interaction with a homotypic HN protein. Investigate the mechanism by which peptide analogs of the F proteins act as highly specific inhibitors of the fusion activity of human parainfluenza viruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy